Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 449

1.

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.

Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG; Children's Oncology Group.

Pediatr Blood Cancer. 2007 Jul;49(1):17-22.

PMID:
16856158
[PubMed - indexed for MEDLINE]
2.

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO.

Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.

PMID:
17158236
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.

Lange BJ, Kobrinsky N, Barnard DR, Arthur DC, Buckley JD, Howells WB, Gold S, Sanders J, Neudorf S, Smith FO, Woods WG.

Blood. 1998 Jan 15;91(2):608-15.

PMID:
9427716
[PubMed - indexed for MEDLINE]
Free Article
4.

Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.

Barnard DR, Lange B, Alonzo TA, Buckley J, Kobrinsky JN, Gold S, Neudorf S, Sanders J, Burden L, Woods WG.

Blood. 2002 Jul 15;100(2):427-34.

PMID:
12091332
[PubMed - indexed for MEDLINE]
Free Article
5.

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center.

Oki Y, Kantarjian HM, Zhou X, Cortes J, Faderl S, Verstovsek S, O'Brien S, Koller C, Beran M, Bekele BN, Pierce S, Thomas D, Ravandi F, Wierda WG, Giles F, Ferrajoli A, Jabbour E, Keating MJ, Bueso-Ramos CE, Estey E, Garcia-Manero G.

Blood. 2006 Feb 1;107(3):880-4. Epub 2005 Aug 25.

PMID:
16123215
[PubMed - indexed for MEDLINE]
Free Article
6.

Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.

Gamis AS, Woods WG, Alonzo TA, Buxton A, Lange B, Barnard DR, Gold S, Smith FO; Children's Cancer Group Study 2891.

J Clin Oncol. 2003 Sep 15;21(18):3415-22. Epub 2003 Jul 28.

PMID:
12885836
[PubMed - indexed for MEDLINE]
7.

Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group.

Woods WG, Barnard DR, Alonzo TA, Buckley JD, Kobrinsky N, Arthur DC, Sanders J, Neudorf S, Gold S, Lange BJ.

J Clin Oncol. 2002 Jan 15;20(2):434-40.

PMID:
11786571
[PubMed - indexed for MEDLINE]
8.

Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.

Bernstein SH, Brunetto VL, Davey FR, Wurster-Hill D, Mayer RJ, Stone RM, Schiffer CA, Bloomfield CD.

J Clin Oncol. 1996 Sep;14(9):2486-94.

PMID:
8823327
[PubMed - indexed for MEDLINE]
9.

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases.

Krance RA, Hurwitz CA, Head DR, Raimondi SC, Behm FG, Crews KR, Srivastava DK, Mahmoud H, Roberts WM, Tong X, Blakley RL, Ribeiro RC.

J Clin Oncol. 2001 Jun 1;19(11):2804-11.

PMID:
11387351
[PubMed - indexed for MEDLINE]
10.

[Acute myeloid leukemia in children with Down syndrome].

Creutzig U, Ritter J, Ludwig WD, Niemeyer C, Reinisch I, Stollmann-Gibbels B, Zimmermann M, Harbott J.

Klin Padiatr. 1995 Jul-Aug;207(4):136-44. German.

PMID:
7564143
[PubMed - indexed for MEDLINE]
11.

Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.

Chan GC, Wang WC, Raimondi SC, Behm FG, Krance RA, Chen G, Freiberg A, Ingram L, Butler D, Head DR.

Leukemia. 1997 Feb;11(2):206-11. Review.

PMID:
9009082
[PubMed - indexed for MEDLINE]
12.

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.

Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheatley K; MRC Childhood Leukemia Working Party.

Blood. 2001 Sep 15;98(6):1714-20.

PMID:
11535502
[PubMed - indexed for MEDLINE]
Free Article
13.

Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.

Aguilera DG, Vaklavas C, Tsimberidou AM, Wen S, Medeiros LJ, Corey SJ.

J Pediatr Hematol Oncol. 2009 Nov;31(11):803-11. doi: 10.1097/MPH.0b013e3181ba43dc.

PMID:
19801947
[PubMed - indexed for MEDLINE]
14.

Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.

Roberson JR, Onciu M, Pounds S, Rubnitz JE, Pui CH, Razzouk BI.

Pediatr Blood Cancer. 2008 Mar;50(3):542-8.

PMID:
17763467
[PubMed - indexed for MEDLINE]
15.

Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.

Castellino SM, Alonzo TA, Buxton A, Gold S, Lange BJ, Woods WG.

Pediatr Blood Cancer. 2008 Jan;50(1):9-16.

PMID:
17252564
[PubMed - indexed for MEDLINE]
16.

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience.

Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR, Srivastava DK, Rubnitz JE, Bowman L, Pui CH, Ribeiro RC.

Blood. 2001 Jun 15;97(12):3727-32.

PMID:
11389009
[PubMed - indexed for MEDLINE]
Free Article
17.

Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis.

Imbert M, Nguyen D, Sultan C.

Leuk Res. 1992;16(1):51-4. Review.

PMID:
1732672
[PubMed - indexed for MEDLINE]
18.
19.

Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.

de Bont ES, Fidler V, Meeuwsen T, Scherpen F, Hählen K, Kamps WA.

Clin Cancer Res. 2002 Sep;8(9):2856-61.

PMID:
12231527
[PubMed - indexed for MEDLINE]
Free Article
20.

Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes.

Kuriyama K, Miyazaki Y, Arimura K, Nagai K, Nakamura H, Matsuo T, Tomonaga M.

Leuk Res. 1995 Feb;19(2):121-5.

PMID:
7869740
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk